✦ LIBER ✦

Comparison of cost-effectiveness of anticoagulation with dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation across countries

✍ Scribed by Krejczy, Martin; Harenberg, Job; Marx, Svetlana; Obermann, Konrad; Frölich, Lutz; Wehling, Martin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

C0126 Value-based pricing for dabigatran

✍ Krejczy, Martin; Marx, Svetlana; Obermann, Konrad; Wehling, Martin; Harenberg, J 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Cost-Effectiveness Analysis of Apixaban

✍ Canal Fontcuberta, C.; Escolar Albaladejo, G.; Betegón Nicolás, L.; de Salas-Can 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Cost-Effectiveness Analysis of Apixaban

✍ Betegón Nicolás, L.; Escolar Albaladejo, G.; Canal Fontcuberta, C.; de Salas-Can 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

C0131 Comparison of the efficacy and saf

✍ Marx, Svetlana; Harenberg, Job; Wehling, Martin; Weiss, Christel; Diener, Hans-C 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Stroke prevention in patients with atria

✍ Lanitis, T.; Cotté, F. E.; Gaudin, A. F.; Kachaner, I.; Kongnakorn, T.; Durand-Z 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 611 KB

Comparative Effectiveness of Dabigatran,

✍ Pink, J. (author);Pirmohamed, M. (author);Hughes, D. A. (author) 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 781 KB